IL-13R α 2 Antibodies

Santa Cruz Biotechnology provides a broad selection of IL-13R α 2 monoclonal antibodies for research focused on understanding this important receptor. IL-13R α 2 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). IL-13R α 2 functions as a critical component in interleukin-13 signaling pathways, playing a central role in immune responses and inflammation. Research has shown IL-13R α 2's significant involvement in modulating allergic reactions and asthma, making it a promising target for therapeutic interventions. Investigating IL-13R α 2 expression and activity continues to reveal new insights into various conditions, including fibrosis and cancer development. Advanced research tools enable scientists to examine IL-13R α 2's cellular distribution, protein interactions, and regulatory mechanisms. Detailed characterization of IL-13R α 2 signaling networks helps illuminate its influence on cellular responses and disease progression. Understanding IL-13R α 2's complex biology may lead to breakthrough treatments for inflammatory and allergic disorders. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific knowledge of IL-13R α 2's role in human health and disease.